Loading clinical trials...
Loading clinical trials...
Evaluation of the Photoprotective Effects of a SPF50+ Sunscreen on Photo-induced Cell Damage in Epidermal and Urine Samples, Following a Repeated Chronic Outdoor Sun Exposure in Healthy Adults
Between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year. Sun protection continues to be a major public health issue and has always been a priority research area for Pierre Fabre laboratories. The involvement of ultraviolet radiation of the solar spectrum in skin carcinogenesis is well known, through its ability to damage the DNA of skin cells and the induction of oxidative processes. The aim of this exploratory study is to perform the quantification of: * DNA photoproducts excised from the genome by the biological repair systems in urine samples * cellular DNA damage in the epidermis following chronic exposure to natural sunlight. This study will allow us to better understand and quantify the benefit of sunscreens on photoinduced cellular damage and their elimination in urine.
This trial is a monocentric, exploratory, randomized, controlled, open-label, parallel-group study conducted in healthy adult subjects. The target population consists of subjects who are accustomed to using few products or using low protection index during sun exposure. The study area is the whole body for sun exposure. The target areas are the face and forearms for the samplings and measurements. In this design, in order not to impose any strong constraint to the subjects in terms of sun exposure, the duration of the exposure period is left free and can vary between 5 and 21 days. Within this window, subjects can freely determine their sun exposure episodes (choice of time slot, number and duration). However, subjects have to expose themselves for at least 3 hours /day, for 5 days in the week prior to visit 2 (which will be scheduled no more than 3 days after their last sun exposure). The study includes 3 visits: * Visit 1: Inclusion (D1) * Visit 2: Intermediate visit (D7 to D39) * Visit 3: Wound healing evaluation and end of study (V2 + 15 days +/- 2 days) The period of outdoor sun exposure varies between 5 and 21 days depending on the duration planned by the subjects themselves. This is also the duration of application of the investigational product for the subjects in group 1. Visit 1 can be performed up to 15 days before the beginning of the sun exposure period and visit 2 up to 3 days after the last sun exposure. The duration of participation for a subject varies between 20 and 56 days (from inclusion to the end of the study).
Age
18 - 55 years
Sex
ALL
Healthy Volunteers
Yes
Skin Research Center
Toulouse, France
Start Date
June 28, 2021
Primary Completion Date
September 13, 2021
Completion Date
September 13, 2021
Last Updated
July 3, 2023
23
ACTUAL participants
Cosmetic product
OTHER
Lead Sponsor
Pierre Fabre Dermo Cosmetique
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions